How the new one-dose COVID-19 vaccine compares to Pfizer and Moderna

This Dec. 2, 2020 photo provided by Johnson & Johnson shows vials of the Janssen COVID-19 vaccine in the United States. Johnson & Johnson’s single-dose vaccine protects against COVID-19, according to an analysis by U.S. regulators Wednesday, Feb. 24, 2021, that sets the stage for a final decision on a new and easier-to-use shot to help tame the pandemic. The Food and Drug Administration’s scientists confirmed that overall, it’s about 66% effective and also said J&J’s shot, one that could help speed vaccinations by requiring just one dose instead of two, is safe to use. (Johnson & Johnson via AP)

A COVID-19 vaccine

→ Continue reading at Mercury News

More from author

Related posts

Advertisment

Latest posts

A Successful Cybersecurity Company Isn't About Fancy Technology

February 25, 2021 6 min read Opinions expressed by Entrepreneur contributors are their own. We’re living in an information age where data is the...

Should You Use Your Own Name or Create a Brand Name for Your Business?

February 25, 2021 6 min read Opinions expressed by Entrepreneur contributors are their own. A friend and ex-colleague of mine recently left her full-time...

Homebuilders grapple with land shortage, soaring lumber costs

By Alex Veiga | The Associated Press U.S. homebuilders are poised to benefit this spring homebuying season amid strong demand, low mortgage rates and...